This blend combines CJC-1295 without DAC (Mod GRF 1-29), a 29-amino acid GHRH analog, with Ipamorelin, a selective pentapeptide ghrelin receptor agonist. The two act on distinct but complementary receptor pathways: CJC-1295 amplifies the amplitude of growth hormone pulses via the GHRH receptor, while Ipamorelin initiates pulse release via GHS-R1a without measurable effect on cortisol, prolactin, or ACTH.
Research Applications:
- Investigation of synergistic GHRH / GHS receptor signaling
- Pulsatile growth hormone secretion studies
- IGF-1 axis and somatotroph response research
- Comparative studies against single-agent GH secretagogues
Specification: 10 mg total per vial (CJC-1295 no-DAC 5 mg + Ipamorelin 5 mg), lyophilized powder, >99% purity.
Storage: Store lyophilized powder at -20°C. After reconstitution with bacteriostatic water, refrigerate at 2-8°C and use within 30 days.
FOR RESEARCH USE ONLY. Not for human or veterinary use. Not for diagnostic or therapeutic purposes.
Reviews
There are no reviews yet.